Rigel Pharmaceuticals (RIGL)

• Market cap: $313M
• 1 day: -3.62%
• 5 days: -4.05%
• 1 month: -21.55%
• 3 months: 0.98%
• 6 months: 9.35%
• Year to date: 1.33%
• 1 year: 31.95%
• 5 years: 21.88%
• 10 years: -52.31%
• Sector: Healthcare
• Industry: Biotechnology

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

3,662% more call options, than puts

Call options by funds: $1.28M | Put options by funds: $34K

300% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 10

126% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 19

32% more funds holding

Funds holding: 92 [Q3] → 121 (+29) [Q4]

5% more capital invested

Capital invested by funds: $193M [Q3] → $203M (+$9.54M) [Q4]

0.65% more ownership

Funds ownership: 67.8% [Q3] → 68.45% (+0.65%) [Q4]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q3] → 1 (-1) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $24 37% upside
• Avg. target: $45 158% upside
• High target: $57 225% upside

3 analyst ratings

• positive: 2 67%
• neutral: 1 33%
• negative: 0 0%

Citigroup Yigal Nochomovitz 18% 1-year accuracy 4 / 22 met price target	213% upside $55	Buy Maintained	6 Mar 2025
B. Riley Securities Kalpit Patel 13% 1-year accuracy 1 / 8 met price target	37% upside $24	Neutral Maintained	5 Mar 2025
HC Wainwright & Co. Joseph Pantginis 17% 1-year accuracy 56 / 327 met price target	225% upside $57	Buy Reiterated	5 Mar 2025